Loading...
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
PURPOSE: Valsartan, an angiotensin-receptor blocker, and rosuvastatin, a competitive inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, are frequently coadministered to treat patients with hypertension and dyslipidemia. The study reported here sought to evaluate the pharmacokinetic an...
Saved in:
| Published in: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354399/ https://ncbi.nlm.nih.gov/pubmed/25767372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76942 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|